Mesothelioma Clinical Trials Search Tool
Find and explore mesothelioma clinical trials with our easy-to-use search tool and get connected with doctors conducting them. Search by location, trial phase, and specific disease presentation to discover cutting-edge treatment opportunities that may fit your diagnosis.
FILTER BY:
Details
SW-682 in Advanced Solid Tumors
Address: 7777 Forest Ln Building C, Dallas, TX 75230
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: Yes
- Peritoneal: No
- Pericardial: No
- Tunica Vaginalis: No
- Therapy Targeted: No
Type: Epitheliod, Biphasic, Sarcomatoid
Condition: Advanced Solid Tumor, Malignant Mesothelioma
Description: This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after appropriate prior systemic anticancer therapy, including chemotherapy, immunotherapy, radiation therapy or targeted therapy, or for which no treatment is available, or prior standard of care (SOC) therapy was not tolerated and for which there is no further SOC treatment available. The study includes a Part 1 (Phase 1a) dose escalation phase and a Part 2 (Phase 1b) dose expansion to optimize the dose to be used for further development. All participants will self-administer SW-682 by mouth in 28-day cycles.
Research Center: Mary Crowley Cancer Research
Treatment Interventions: DRUG: SW-682, DRUG: Combination Therapy
Clinical Trial Number: NCT06251310
Phase: Phase 1
Status: Recruiting
